Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?

Iris Lee, Serban Constantinescu, Avrum Gillespie, Abhishek Swami, Mark Birkenbach, Stephen Leech, Patricio Silva, Andreas Karachristos, John A. Daller, Nicole M. Sifontis

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)425-429
Number of pages5
JournalClinical transplants
StatePublished - 2009

Cite this